請用 Wechat 掃描台灣精品QRcode 或 搜尋ID: TaiwanExcellence
- Taiwan Excellence Award
- Award Winning Products
- Shop Online
PixoTest POCT System integrates HbA1c and Lipid tests with one portable, handheld designed Analyzer. It takes only three minutes to complete the tests and produces accurate lab-quality performance that is NGSP certified. The system is extensible with modular test slots for multiple testing on the same device. The embedded mobile device enables seamless data transmission to the cloud and connection to the point-of-care facilities for better patient data management.
Portable: Handheld design for ease of carrying to the community
Extensible: Modular test slot for multiple tests on the same device
Efficient: Tests completed in 3 minutes.
Accurate: Lab quality result with NGSP certified
eManagement: Test data can be seamlessly uploaded to the cloud and connected to the management system of community- based point- of- care facility.
About iXensor Co., Ltd.
iXensor, the pioneer of mobile health, turns smartphones into lab-grade medical diagnostics, democratizing medical tests for the public. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world's first US FDA-approved smartphone camera-based blood test. Based on the core PixoTech® platform, iXensor has ventured into at-home self-testing and clinical point-of-care diagnostics with product brand, PixoTest®, across infectious diseases, chronic diseases and Eveline® for women's health. Since 2020, iXensor has extended the new business model with PixoTech® licensing, facilitating the digital transformation for multinational strategic partners' IVD business.
PixoTest® represents iXensor's mobile diagnostics' product line, signifying our digital color and image sensing technology. The word Pixo sheds light on its pioneering position as the world's first US FDA approved image quantification technology for smartphone-based medical tests; and Test pinpoints its core strength of decentralizing quality medical testing for billions of mobile phone users. The brand conveys infinite possibilities of personalized digital healthcare. Since the launch in 2017, PixoTest® unleashed the unique advantage of decentralized medical testing, transformed traditional healthcare model, which relies heavily on hospitals and clinics, in Europe, Africa and Taiwan. PixoTest® completes several innovative healthcare models such as at-home care and telemedicine, by making decentralized and connected medical testing possible with its rapid diagnostics for patients of chronic diseases and infectious diseases in the international realm of digital health.